Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

FDA approval of benzgalantamine exposes flaws in the 505(b)(2) pathway for innovations on existing drugs.

PMID: 41771551 · 2026

JournalBMJ evidence-based medicine
Year2026
PMID41771551

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.

↑